Gavestinel

DB06741

small molecule investigational

Deskripsi

Highly potent and selective non-competitive antagonist acting at the strychnine-insensitive glycine binding site of the NMDA receptor-channel complex (Kd = 0.8 nM). Gavestinel displays > 1000-fold selectivity over NMDA, AMPA and kainate binding sites and is orally bioavailable and active in vivo.

Struktur Molekul 2D

Berat 375.21
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

59 Data
Nelfinavir The metabolism of Gavestinel can be increased when combined with Nelfinavir.
Phenytoin The metabolism of Gavestinel can be increased when combined with Phenytoin.
Desogestrel The metabolism of Gavestinel can be increased when combined with Desogestrel.
Zidovudine The metabolism of Gavestinel can be increased when combined with Zidovudine.
Ritonavir The metabolism of Gavestinel can be increased when combined with Ritonavir.
Lamotrigine The metabolism of Gavestinel can be increased when combined with Lamotrigine.
Carbamazepine The metabolism of Gavestinel can be increased when combined with Carbamazepine.
Efavirenz The metabolism of Gavestinel can be increased when combined with Efavirenz.
Primidone The metabolism of Gavestinel can be increased when combined with Primidone.
Tipranavir The metabolism of Gavestinel can be increased when combined with Tipranavir.
Ethinylestradiol The metabolism of Gavestinel can be increased when combined with Ethinylestradiol.
Rifampin The metabolism of Gavestinel can be increased when combined with Rifampicin.
Phenobarbital The metabolism of Gavestinel can be increased when combined with Phenobarbital.
Testosterone propionate The metabolism of Gavestinel can be increased when combined with Testosterone propionate.
Adenine The metabolism of Gavestinel can be decreased when combined with Adenine.
Indinavir The metabolism of Gavestinel can be decreased when combined with Indinavir.
Valproic acid The metabolism of Gavestinel can be decreased when combined with Valproic acid.
Amitriptyline The metabolism of Gavestinel can be decreased when combined with Amitriptyline.
Indomethacin The metabolism of Gavestinel can be decreased when combined with Indomethacin.
Sorafenib The metabolism of Gavestinel can be decreased when combined with Sorafenib.
Erlotinib The metabolism of Gavestinel can be decreased when combined with Erlotinib.
Flurbiprofen The metabolism of Gavestinel can be decreased when combined with Flurbiprofen.
Propofol The metabolism of Gavestinel can be decreased when combined with Propofol.
Ketoconazole The metabolism of Gavestinel can be decreased when combined with Ketoconazole.
Probenecid The metabolism of Gavestinel can be decreased when combined with Probenecid.
Atazanavir The metabolism of Gavestinel can be decreased when combined with Atazanavir.
Gemfibrozil The metabolism of Gavestinel can be decreased when combined with Gemfibrozil.
Flunitrazepam The metabolism of Gavestinel can be decreased when combined with Flunitrazepam.
Deferasirox The metabolism of Gavestinel can be decreased when combined with Deferasirox.
Nilotinib The metabolism of Gavestinel can be decreased when combined with Nilotinib.
Eltrombopag The metabolism of Gavestinel can be decreased when combined with Eltrombopag.
Pazopanib The metabolism of Gavestinel can be decreased when combined with Pazopanib.
Regorafenib The metabolism of Gavestinel can be decreased when combined with Regorafenib.
Dasabuvir The metabolism of Gavestinel can be decreased when combined with Dasabuvir.
Sodium aurothiomalate The metabolism of Gavestinel can be decreased when combined with Sodium aurothiomalate.
Ombitasvir The metabolism of Gavestinel can be decreased when combined with Ombitasvir.
Paritaprevir The metabolism of Gavestinel can be decreased when combined with Paritaprevir.
Silibinin The metabolism of Gavestinel can be decreased when combined with Silibinin.
Dacomitinib The metabolism of Gavestinel can be decreased when combined with Dacomitinib.
Fostamatinib The metabolism of Gavestinel can be decreased when combined with Fostamatinib.
Enasidenib The metabolism of Gavestinel can be decreased when combined with Enasidenib.
Pibrentasvir The metabolism of Gavestinel can be decreased when combined with Pibrentasvir.
Glecaprevir The metabolism of Gavestinel can be decreased when combined with Glecaprevir.
Pexidartinib The metabolism of Gavestinel can be decreased when combined with Pexidartinib.
Mefenamic acid The metabolism of Gavestinel can be decreased when combined with Mefenamic acid.
Diflunisal The metabolism of Gavestinel can be decreased when combined with Diflunisal.
Fosphenytoin The metabolism of Gavestinel can be decreased when combined with Fosphenytoin.
Isavuconazole The metabolism of Gavestinel can be decreased when combined with Isavuconazole.
Umifenovir The metabolism of Gavestinel can be decreased when combined with Umifenovir.
Methylene blue The metabolism of Gavestinel can be decreased when combined with Methylene blue.
Niflumic acid The metabolism of Gavestinel can be decreased when combined with Niflumic acid.
Cannabidiol The metabolism of Gavestinel can be decreased when combined with Cannabidiol.
Dovitinib The metabolism of Gavestinel can be decreased when combined with Dovitinib.
Asciminib The metabolism of Gavestinel can be decreased when combined with Asciminib.
Mitapivat The metabolism of Gavestinel can be increased when combined with Mitapivat.
Dabrafenib The metabolism of Gavestinel can be decreased when combined with Dabrafenib.
Quizartinib The metabolism of Gavestinel can be decreased when combined with Quizartinib.
Repotrectinib The metabolism of Gavestinel can be decreased when combined with Repotrectinib.
Encorafenib The metabolism of Gavestinel can be decreased when combined with Encorafenib.

Target Protein

Glycine receptor subunit alpha-1 GLRA1
Glycine receptor subunit alpha-2 GLRA2
Glycine receptor subunit alpha-3 GLRA3
Glycine receptor subunit beta GLRB
Glutamate (NMDA) receptor GRIN1

Referensi & Sumber

Artikel (PubMed)
  • PMID: 16340185
    Warach S, Kaufman D, Chiu D, Devlin T, Luby M, Rashid A, Clayton L, Kaste M, Lees KR, Sacco R, Fisher M: Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy. Cerebrovasc Dis. 2006;21(1-2):106-11. Epub 2005 Dec 9.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul